Suitability assessment of baseline concentration of MMP3, TIMP3, HE4 and CA125 in the serum of patients with ovarian cancer

J Ovarian Res. 2018 Jan 5;11(1):1. doi: 10.1186/s13048-017-0373-9.

Abstract

Background: MMP and TIMP play an important role in the degradation of extracellular matrix components which are essential for tumor growth, invasion and metastasis. Aim of this research was to assess MMP3 and TIMP3 as prognostic factors among patients with ovarian cancer.

Results: It was found that high levels of output MMP3 correlated with shortened overall survival time of patients by 9.7 months. In addition, it has been shown that high concentrations of output MMP3 were significantly associated with a shorter disease free time in median concentrations implemented p = 0.0059. Statistically significant dependence has been shown between an average concentration of TIMP3 protein to the overall survival of patients. The higher output concentration of TIMP3, the longer patients' survival by 8.9 month. In addition, it was found that high TIMP3 concentrations output were associated with a significantly longer disease free duration at a median concentrations p = 0.007.

Conclusion: Preliminary research shows that output levels of MMP3 and TIMP3 proteins correlate with overall survival of patients. In some cases also time free of illness.

Keywords: MMP3; Ovarian cancer; Overall survival; PFS; TIMP3.

MeSH terms

  • Adult
  • Aged
  • Biomarkers, Tumor*
  • CA-125 Antigen / blood*
  • Combined Modality Therapy
  • Disease Progression
  • Female
  • Humans
  • Kaplan-Meier Estimate
  • Matrix Metalloproteinase 3 / blood*
  • Middle Aged
  • Neoplasm Grading
  • Neoplasm Staging
  • Ovarian Neoplasms / blood*
  • Ovarian Neoplasms / diagnosis
  • Ovarian Neoplasms / mortality
  • Ovarian Neoplasms / therapy
  • Prognosis
  • Proportional Hazards Models
  • Proteins*
  • ROC Curve
  • Reproducibility of Results
  • Tissue Inhibitor of Metalloproteinase-3 / blood*
  • Tomography, X-Ray Computed
  • Ultrasonography
  • WAP Four-Disulfide Core Domain Protein 2

Substances

  • Biomarkers, Tumor
  • CA-125 Antigen
  • Proteins
  • Tissue Inhibitor of Metalloproteinase-3
  • WAP Four-Disulfide Core Domain Protein 2
  • WFDC2 protein, human
  • Matrix Metalloproteinase 3